Insider · CIK 0001791249

Ackermann Michael

Reports to the SEC for 2 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001791249

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-16	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2022-06-16	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+12K sh	—	—	12,000
2022-06-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,257 sh	—	—	0
2022-06-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,257 sh	—	—	1,208,273
2022-05-05	TARSTarsus Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+100K sh	$13.50	+$1.35M	100,000
2021-12-01	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−2,054 sh	$24.68	−$50.7K	1,205,353
2021-12-01	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−528 sh	$26.65	−$14.1K	1,204,016
2021-12-01	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−809 sh	$25.87	−$20.9K	1,204,544
2021-12-01	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−2,442 sh	$23.85	−$58.2K	1,207,407
2021-11-01	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−4,964 sh	$27.76	−$138K	1,210,718
2021-11-01	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−869 sh	$28.18	−$24.5K	1,209,849
2021-10-12	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−4,517 sh	$26.45	−$119K	1,215,682
2021-10-12	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−1,116 sh	$25.56	−$28.5K	1,220,199
2021-10-08	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−200 sh	$25.03	−$5,006	1,221,315
2021-09-01	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−5,833 sh	$25.24	−$147K	1,221,515
2021-08-11	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−621 sh	$25.15	−$15.6K	1,227,348
2021-08-09	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−700 sh	$25.00	−$17.5K	1,227,969
2021-08-06	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−3,129 sh	$25.00	−$78.2K	1,228,669
2021-08-05	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−1,183 sh	$25.00	−$29.6K	1,231,998
2021-08-05	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−100 sh	$25.00	−$2,500.5	1,231,898
2021-08-05	TARSTarsus Pharmaceuticals, Inc.S Sale	Director	SSale	−100 sh	$25.01	−$2,501	1,231,798
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,257 sh	—	—	4,257
2021-06-15	TARSTarsus Pharmaceuticals, Inc.A Award	Director	AAward	+4,257 sh	—	—	1,233,181
2020-10-20	TARSTarsus Pharmaceuticals, Inc.C Conversion	Director	CConversion	+9,246 sh	—	—	1,228,924
2020-10-20	TARSTarsus Pharmaceuticals, Inc.C Conversion	Director	CConversion	+53.9K sh	—	—	1,219,678
2020-10-20	TARSTarsus Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−53.9K sh	—	—	0
2020-10-20	TARSTarsus Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−9,246 sh	—	—	0
2020-06-08	Oyster Point Pharma, Inc.A Award	Director	AAward	+14.8K sh	—	—	152,162
2019-11-04	Oyster Point Pharma, Inc.C Conversion	Director	CConversion	+141K sh	—	—	140,567
2019-11-04	Oyster Point Pharma, Inc.Series A Convertible Preferred StockC Conversion	Director	CConversion	−141K sh	—	—	0

Recent filings

Accepted (ET)
Jul 14
Ackermann Michael0001628280-22-018349
SEC(opens sec.gov)
Jun 174
Ackermann Michael0001209191-22-037924
SEC(opens sec.gov)
May 94
Ackermann Michael0001209191-22-027856
SEC(opens sec.gov)
Dec 34
Ackermann Michael0001819790-21-000059
SEC(opens sec.gov)
Nov 34
Ackermann Michael0001819790-21-000043
SEC(opens sec.gov)
Oct 144
Ackermann Michael0001819790-21-000039
SEC(opens sec.gov)
Oct 124
Ackermann Michael0001819790-21-000035
SEC(opens sec.gov)
Sep 34
Ackermann Michael0001209191-21-054888
SEC(opens sec.gov)
Aug 124
Ackermann Michael0001209191-21-051193
SEC(opens sec.gov)
Aug 104
Ackermann Michael0001209191-21-050631
SEC(opens sec.gov)
Aug 64
Ackermann Michael0001209191-21-050177
SEC(opens sec.gov)

Companies

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540